Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
SSE:603896.SS
22.31 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 853.642 | 1,503.962 | 1,524.712 | 677.984 | 669.248 | 205.624 | 166.024 | 89.191 | 4.675 | 18.238 | 40.899 | 77.13 | 48.155 |
| Short Term Investments
| 344.689 | 0 | 30 | 130 | 50 | 198.5 | -273.512 | -177.915 | -144.259 | -160.942 | -74.927 | -74.874 | -64.098 |
| Cash and Short Term Investments
| 1,198.332 | 1,503.962 | 1,554.712 | 807.984 | 719.248 | 404.124 | 166.024 | 89.191 | 4.675 | 18.238 | 40.899 | 77.13 | 48.155 |
| Net Receivables
| 122.163 | 124.341 | 137.679 | 117.248 | 88.256 | 68.463 | 66.374 | 36.935 | 38.056 | 40.635 | 36.946 | 42.937 | 38.233 |
| Inventory
| 179.551 | 157.833 | 147.756 | 99.062 | 99.377 | 110.095 | 118.617 | 112.701 | 101.122 | 78.573 | 58.481 | 56.82 | 56.657 |
| Other Current Assets
| 22.303 | 20.709 | 21.864 | 21.005 | 15.921 | 20.286 | 181.006 | 244.732 | 23.005 | 21.795 | 6.846 | 65.299 | 40.366 |
| Total Current Assets
| 1,522.349 | 1,806.846 | 1,862.011 | 1,045.299 | 922.803 | 602.968 | 532.021 | 483.559 | 166.858 | 159.241 | 143.172 | 234.003 | 145.178 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 883.703 | 650.937 | 570.966 | 493.498 | 354.709 | 288.865 | 247.968 | 148.761 | 200.163 | 195.833 | 135.323 | 80.519 | 50.157 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 352.859 | 310.977 | 78.158 | 82.978 | 78.577 | 80.843 | 74.259 | 77.504 | 76.711 | 61.709 | 3.577 | 3.593 | 3.541 |
| Goodwill and Intangible Assets
| 352.859 | 310.977 | 78.158 | 82.978 | 78.577 | 80.843 | 74.259 | 77.504 | 76.711 | 61.709 | 3.577 | 3.593 | 3.541 |
| Long Term Investments
| -249.836 | 65.714 | 33.802 | -63.54 | 32.122 | -107.232 | 329.792 | 211.426 | 164.454 | 180.354 | 95.197 | 87.114 | 72.709 |
| Tax Assets
| 553.46 | 0 | -33.802 | 0.374 | 1.042 | 1.025 | 0.304 | 0.616 | 0.563 | 0.497 | 0.428 | 0.072 | 0.078 |
| Other Non-Current Assets
| 622.111 | 339.881 | 345.054 | 403.85 | 310.331 | 474.315 | 7.183 | 4.479 | 3.345 | 8.273 | 123.295 | 4.05 | 2.343 |
| Total Non-Current Assets
| 1,608.837 | 1,367.508 | 994.178 | 917.161 | 776.78 | 737.816 | 659.506 | 442.786 | 445.237 | 446.666 | 357.819 | 175.35 | 128.828 |
| Total Assets
| 3,131.186 | 3,174.354 | 2,856.19 | 1,962.46 | 1,699.583 | 1,340.784 | 1,191.527 | 926.344 | 612.095 | 605.908 | 500.992 | 409.353 | 274.006 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 137.17 | 145.818 | 143.955 | 140.808 | 90.183 | 26.001 | 34.657 | 22.96 | 20.136 | 38.978 | 45.31 | 27.888 | 31.234 |
| Short Term Debt
| 187.4 | 372.161 | 272.972 | 0 | 0 | 10 | 40 | 0 | 123 | 167.6 | 104 | 43.5 | 36 |
| Tax Payables
| 7.414 | 9.531 | 8.215 | 4.107 | 6.982 | 7.525 | 9.354 | 3.103 | 5.414 | 1.926 | 8.698 | 6.275 | 3.965 |
| Deferred Revenue
| 0 | 10.105 | 9.034 | 50.799 | 7.715 | 36.865 | 9.354 | 5.594 | 19.295 | 16.471 | 20.113 | 18.221 | 46.219 |
| Other Current Liabilities
| 58.197 | 47.533 | 52.622 | 44.757 | 67.529 | 104.663 | 111.761 | 21.992 | 13.88 | 17.244 | 13.925 | 13.799 | 43.888 |
| Total Current Liabilities
| 390.181 | 585.147 | 477.765 | 199.276 | 164.694 | 146.451 | 195.771 | 48.055 | 165.365 | 225.747 | 171.933 | 91.463 | 115.087 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 383.768 | 364.158 | 428.561 | 100.929 | 188.126 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 14 |
| Deferred Revenue Non-Current
| 54.862 | 49.984 | 41.298 | 38.225 | 16.121 | 16.529 | 11.017 | 8.541 | 9.804 | 11.631 | 8.494 | 7.39 | 6.55 |
| Deferred Tax Liabilities Non-Current
| 8.355 | 3.777 | 3.044 | 3.979 | 4.335 | 5.335 | 4.482 | 0 | 0 | 0 | 0 | -11 | -14 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | -4.482 | 0 | 0 | 0 | 0 | 0 | 6.55 |
| Total Non-Current Liabilities
| 446.985 | 417.919 | 472.902 | 143.134 | 208.582 | 21.864 | 11.017 | 8.541 | 9.804 | 11.631 | 8.494 | 18.39 | 20.55 |
| Total Liabilities
| 837.166 | 1,003.066 | 950.667 | 342.41 | 373.277 | 168.315 | 206.788 | 56.596 | 175.169 | 237.378 | 180.427 | 109.853 | 135.637 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 100.931 | 0 | 46.756 | 29.865 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 198.244 | 201.829 | 197.203 | 152.498 | 148.011 | 143.872 | 143.335 | 139.8 | 104.85 | 104.85 | 104.85 | 104.85 | 56.5 |
| Retained Earnings
| 1,072.173 | 974.774 | 815.768 | 613.698 | 468.942 | 375.168 | 292.987 | 225.134 | 163.098 | 102.132 | 64.561 | 48.415 | 19.39 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 92.829 | 36.305 | -46.756 | -29.865 | 68.584 | 573.36 | 504.814 | 28.688 | 21.258 | -0 | -0 | 0 |
| Other Total Stockholders Equity
| 1,023.602 | 800.926 | 892.551 | 900.225 | 709.354 | 653.43 | 573.36 | 504.814 | 140.29 | 140.29 | 162.019 | 146.235 | 62.48 |
| Total Shareholders Equity
| 2,294.019 | 2,171.289 | 1,905.522 | 1,619.665 | 1,326.306 | 1,172.47 | 984.738 | 869.748 | 436.926 | 368.53 | 320.565 | 299.5 | 138.369 |
| Total Equity
| 2,294.019 | 2,171.289 | 1,905.522 | 1,620.049 | 1,326.306 | 1,172.47 | 984.738 | 869.748 | 436.926 | 368.53 | 320.565 | 299.5 | 138.369 |
| Total Liabilities & Shareholders Equity
| 3,131.186 | 3,174.354 | 2,856.19 | 1,962.46 | 1,699.583 | 1,340.784 | 1,191.527 | 926.344 | 612.095 | 605.908 | 500.992 | 409.353 | 274.006 |